Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antisense Oligonucleotide Therapy Decreases IL-1β Expression and Prolongs Survival in Mutant Nlrp3 Mice

The Journal of Immunology(2023)10.4049/jimmunol.2200550Source: DataRank Database

Antisense Oligonucleotide Therapy Decreases IL-1β Expression and Prolongs Survival in Mutant Nlrp3 Mice is a research paper published in The Journal of Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

9 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.84)OA: closedTopics (40)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Marta de los Reyes Jiménez ORCID,Laela M. Booshehri ORCID,Janset Onyuru ORCID,Aleksandra Leszczynska ORCID,Anna Uri

Live enrichment

PubMed:37256266 OpenAlex:https://openalex.org/W4378781067

HHS | National Institutes of Health

Grant: R01 DK113592

HHS | National Institutes of Health

Grant: R01 AA024206

Deutsche Forschungsgemeinschaft

Grant: KA 5089/1-1

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

FWCI

0.84

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

closedLicense: OUP Standard Publication Reuse

publisherhttps://academic.oup.com/jimmunol/article-pdf/211/2/287/61472056/ji2200550.pdf

journalhttps://doi.org/10.4049/jimmunol.2200550

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37256266

Fields of Study

Inflammasome and immune disordersIL-33, ST2, and ILC PathwaysImmune Response and Inflammation03 medical and health sciences0302 clinical medicine

MeSH Terms

NLR Family, Pyrin Domain-Containing 3 ProteinAnimalsCarrier ProteinsInflammationMiceInterleukin-1betaCryopyrin-Associated Periodic SyndromesInflammasomesCryopyrin-associated Periodic Syndromes

Keywords

MutantIn vivoPyrin domainDownregulation and upregulationEx vivoOligonucleotideInflammationMolecular biologyReceptorWild typeCancer researchInflammasomeCell biologyChemistryBiologyGeneImmunologyBiochemistryGeneticsMiceInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinInterleukin-1betaAnimalsCarrier ProteinsCryopyrin-Associated Periodic Syndromes

Sustainable Development Goals

SDG 0: Good health and well-being